3B.1 Overview and rationale for the cost-minimisation approach

Page last updated: September 2016

Information Requests

  • Summarise the key components and assumptions of the approach (Subsection 3B.1.1)

3B.1.1 Summary table of cost-minimisation approach

Complete Table 3B.1.1 to summarise the key assumptions and components of the cost-minimisation approach.

Table 3B.1.1 Key assumptions and components of the cost-minimisation approach

Component

Claim or assumption

Therapeutic claim: effectiveness

Based on evidence presented in Section 2, effectiveness is assumed to be [noninferior/superior]

Therapeutic claim: safety

Based on evidence presented in Section 2, safety is assumed to be [noninferior/superior]

Evidence base

[direct randomised trials/indirect comparison of randomised trials]

Equi-effective doses

Proposed medicine [describe dose/day/course] and comparator [describe dose/day/course]

Direct medicine costs

[lower/equivalent/higher]; [cost of proposed medicine] vs [cost of comparator] (costs are per patient per course for an acute or self-limited therapy, or per patient per year for a chronic or continuing therapy)

Other costs or cost offsets

[Yes/No] [if yes; brief description – eg adverse effect–related costs, monitoring costs, administration costs]